Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mallolas

Showing results (121-130 of 137) with videos related to

Pageof 14
Sort By:
HIV Medicine|March 28, 2008
Hepatotoxicity of nevirapine in virologically suppressed patients according to gender and CD4 cell countsE De Lazzari, A León, J A Arnaiz, et al.
HIV Medicine|October 24, 2012
Differences between HIV-infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel case-control studiesM Calvo-Sánchez, R Perelló, I Pérez, et al.
HIV Medicine|May 11, 2018
Subclinical cardiovascular disease in patients starting contemporary protease inhibitorsA González-Cordón, M Doménech, M Camafort, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2003
Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapyJuan Berenguer, Pilar Miralles, Julio Arrizabalaga, et al.
AIDS (London, England)|June 27, 2001
Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapyE Martínez, J L Blanco, J A Arnaiz, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 24, 2013
Acquisition of resistant microorganisms and infections in HIV-infected patients admitted to the ICUN Cobos-Trigueros, M Rinaudo, M Solé, et al.
The Journal of Antimicrobial Chemotherapy|November 2, 2017
Tenofovir disoproxil fumarate/emtricitabine plus ritonavir-boosted lopinavir or cobicistat-boosted elvitegravir as a single-tablet regimen for HIV post-exposure prophylaxisA Inciarte, L Leal, E González, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Dose-finding study of once-daily indinavir/ritonavir plus zidovudine and lamivudine in HIV-infected patientsJ Mallolas, J L Blanco, M Sarasa, et al.
Antiviral Therapy|April 1, 1996
A pilot case-control study of zidovudine compared with zidovudine plus didanosine in patients with advanced HIV-1 disease and no previous experience with antiretroviralsJ M Gatell, M Leal, J Mallolas, et al.
The Journal of Antimicrobial Chemotherapy|April 14, 2009
Pegylated interferon {alpha}2a plus ribavirin versus pegylated interferon {alpha}2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patientsJ Berenguer, J González-García, J López-Aldeguer, et al.
Pageof 14

Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
HIV Medicine|March 28, 2008
Hepatotoxicity of nevirapine in virologically suppressed patients according to gender and CD4 cell countsE De Lazzari, A León, J A Arnaiz, et al.
HIV Medicine|October 24, 2012
Differences between HIV-infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel case-control studiesM Calvo-Sánchez, R Perelló, I Pérez, et al.
HIV Medicine|May 11, 2018
Subclinical cardiovascular disease in patients starting contemporary protease inhibitorsA González-Cordón, M Doménech, M Camafort, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2003
Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapyJuan Berenguer, Pilar Miralles, Julio Arrizabalaga, et al.
AIDS (London, England)|June 27, 2001
Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapyE Martínez, J L Blanco, J A Arnaiz, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 24, 2013
Acquisition of resistant microorganisms and infections in HIV-infected patients admitted to the ICUN Cobos-Trigueros, M Rinaudo, M Solé, et al.
The Journal of Antimicrobial Chemotherapy|November 2, 2017
Tenofovir disoproxil fumarate/emtricitabine plus ritonavir-boosted lopinavir or cobicistat-boosted elvitegravir as a single-tablet regimen for HIV post-exposure prophylaxisA Inciarte, L Leal, E González, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Dose-finding study of once-daily indinavir/ritonavir plus zidovudine and lamivudine in HIV-infected patientsJ Mallolas, J L Blanco, M Sarasa, et al.
Antiviral Therapy|April 1, 1996
A pilot case-control study of zidovudine compared with zidovudine plus didanosine in patients with advanced HIV-1 disease and no previous experience with antiretroviralsJ M Gatell, M Leal, J Mallolas, et al.
The Journal of Antimicrobial Chemotherapy|April 14, 2009
Pegylated interferon {alpha}2a plus ribavirin versus pegylated interferon {alpha}2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patientsJ Berenguer, J González-García, J López-Aldeguer, et al.
Pageof 14